Shumei Kato
0000-0003-1193-1815
6 papers found
Refreshing results…
Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study
Epidermal Growth Factor Receptor Inhibition in Epidermal Growth Factor Receptor–Amplified Gastroesophageal Cancer: Retrospective Global Experience
Real-World Data From a Molecular Tumor Board: Improved Outcomes in Breast and Gynecologic Cancers Patients With Precision Medicine
Hyperprogression in Gastric Cancer: Is MDM2 Amplification the Dark Horse?
Dose‐escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF‐mutated advanced cancers
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF ‐mutated melanoma and other advanced malignancies
Missing publications? Search for publications with a matching author name.